The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are widely used to treat HIV-1-infected individuals; indeed most first-line antiretroviral therapies typically include one NNRTI in combination with two nucleoside analogs. In 2008, the next-generation NNRTI etravirine was approved for the trea...

Descripción completa

Detalles Bibliográficos
Autor principal: Sluis-Cremer, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147682/
https://www.ncbi.nlm.nih.gov/pubmed/25089538
http://dx.doi.org/10.3390/v6082960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147682/
https://www.ncbi.nlm.nih.gov/pubmed/25089538
http://dx.doi.org/10.3390/v6082960

Ejemplares similares